Literature DB >> 2933518

Stereoselectivity of muscarinic receptors in vivo and in vitro for oxotremorine analogues. N-[4-(tertiary amino)-2-butynyl]-5-methyl-2-pyrrolidones.

R Amstutz, B Ringdahl, B Karlén, M Roch, D J Jenden.   

Abstract

The enantiomers of three 5-methyl-2-pyrrolidone analogues of the muscarinic agent oxotremorine (1) were synthesized. The pyrrolidine derivative (R)-13 was an antagonist to carbachol in the guinea pig ileum and also showed central and peripheral antimuscarinic activity in vivo. It was more potent and more selective than atropine in antagonizing the central effects of 1. The dimethylamino analogue (R)-14 and the trimethylammonium salt (R)-15 were potent agonists in the guinea pig ileum. (R)-14 showed both central muscarinic (hypothermia) and central antimuscarinic activity (antagonism of oxotremorine-induced tremor) in vivo. The R enantiomers of 13-15 were considerably more potent than the S enantiomers in vivo and in vitro irrespective of whether agonist or antagonist activity was measured. From a comparison of the contribution of the methyl group at the chiral center to the overall affinities, it is suggested that agonists and antagonists in this series bind in an essentially identical manner to the muscarinic receptor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2933518     DOI: 10.1021/jm00150a004

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Developing microcolin A analogs as biological probes.

Authors:  Amit K Mandal; John Hines; Kouji Kuramochi; Craig M Crews
Journal:  Bioorg Med Chem Lett       Date:  2005-09-15       Impact factor: 2.823

2.  Dissociation constants and relative efficacies of acetylcholine, (+)- and (-)-methacholine at muscarinic receptors in the guinea-pig ileum.

Authors:  B Ringdahl
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

3.  Structure-activity relationships of new analogues of arecaidine propargyl ester at muscarinic M1 and M2 receptor subtypes.

Authors:  U Moser; G Lambrecht; M Wagner; J Wess; E Mutschler
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.